for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reuters Now

Valeant stock tanks after warning of default

Posted

Valeant Pharmaceuticals on Tuesday cut its 2016 revenue forecast by about 12 percent and said a delay in filing its annual report could mean a debt default, causing its shares to plunge.

Reuters Now

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up